A group of researchers at New York University has developed a new type of gear system that uses fluid motion to produce ...
ReviR Therapeutics today announced a strategic investment from CureCMT to support the launch of a precision medicine platform for Charcot-Marie-Tooth disease (CMT). The platform will combine isogenic ...
A highly selective TASK-1 inhibitor designed to restore rhythm and rate with improved safety — moving toward First-in-Human studies OCALA, FL, UNITED STATES, April ...
HSSA Funding to Support Commercialization of Biological Testing Platform and High-Paying Bioscience Jobs in Spokane SPOKANE, WA, UNITED STATES, March 31, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results